PrimeRFP
PrimeRFP SCOUT · Federal Contract Recompete Brief

15F06722F0000478Vaccines including BUT NOT limited to — Sanofi Pasteur Inc

Sanofi Pasteur Inc holds $3.7B across 396 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 15F06722A0000207. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Feb 26, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Division 1200
Awarding office
Sanofi Pasteur Inc
Recipient
Feb 26, 2025
PoP end
$542K
Obligated
$625K
Potential
325412
NAICS
6515
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Sanofi Pasteur Inc — $90

Contract facts

NONE
Contract number15F06722F0000478
Also listed as15F06722A0000207-15F06722F0000478
AgencyDivision 1200
Awarding officeDivision 1200
Awarding agencyDepartment of Justice (DOJ)
Funding agencyDepartment of Justice (DOJ)
IncumbentSanofi Pasteur Inc
CAGE7V915
UEINCXBGGQ8YTU9
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6515
Parent IDIQ / IDV15F06722A0000207
Place of performanceSWIFTWATER PA
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
PoP startMar 22, 2022
PoP end (current)Feb 26, 2025
Obligated$542K
Current value$625K
Potential value$625K

VACCINES INCLUDING BUT NOT LIMITED TO: HEPATITIS A, HEPATITIS B, COMBINED HEPATITIS A AND B, MMR MEASLES, MUMPS, RUBELLA, TD TETANUS, DIPHTHERIA, TDAP TETANUS, DIPHTHERIA AND PERTUSSIS, MENINGITIS, RABIES, POLIO, TYPHOID INJECTABLE AND ORAL, YELLOW is a federal NONE award for Division 1200 held by Sanofi Pasteur Inc. Estimated value $625K ($542K obligated). Current period of performance ends Feb 26, 2025. Last award drew 1 bidder. Place of performance: SWIFTWATER PA.

VACCINES INCLUDING BUT NOT LIMITED TO: HEPATITIS A, HEPATITIS B, COMBINED HEPATITIS A AND B, MMR MEASLES, MUMPS, RUBELLA, TD TETANUS, DIPHTHERIA, TDAP TETANUS, DIPHTHERIA AND PERTUSSIS, MENINGITIS, RABIES, POLIO, TYPHOID INJECTABLE AND ORAL, YELLOW

Recompete timing

Public
● Past PoP end (562 days ago)

Current PoP ended Feb 26, 2025 (562 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Sanofi Pasteur Inc — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.7B) · all agencies · Top 4 shown (98%); remaining ~2% is other agencies.
Department of Health and Human Services (HHS)$3.6B · 97%Department of Defense (DOD)$29.1M · 1%Department of Veterans Affairs (VA)$6.9M · 0%Department of State (DOS)$2.4M · 0%
Open full company profile →

Related awards

Same parent · incumbent
SPE2DP26F2910
8511928943!INFLUENZA VIRUS VAC
$3.0M
Sep 25, 2026
SPE2DP26F2847
8511923395!INFLUENZA VIRUS VAC
$2.9M
Sep 25, 2026
SPE2DP26F2909
8511928883!INFLUENZA VIRUS VAC
$824K
Sep 25, 2026
15F06724F0000477
TRAVEL VACCINES.
$504K
Dec 31, 2026
15F06726F0000243
SANOFI TRAVEL VACCINES
$200K
Dec 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 15F06722F0000478?

15F06722F0000478 (Vaccines including BUT NOT limited to) is a Division 1200 award with a potential value of $625K, currently held by Sanofi Pasteur Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 15F06722F0000478?

Division 1200 awarded 15F06722F0000478 to Sanofi Pasteur Inc (potential $625K).

Who is the incumbent on 15F06722F0000478?

Sanofi Pasteur Inc is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint. The current period of performance ends Feb 26, 2025.

When does Sanofi Pasteur Inc’s 15F06722F0000478 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 26, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 15F06722F0000478 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/15F06722F0000478